ERRIA OPJUSTERER FORVENTNINGERNE TIL ÅRETS RESULTAT
Selskabsmeddelelse Nr. 01/2023 – 27. februar 2023 Indeholder Insider information ERRIA OPJUSTERER FORVENTNINGERNE TIL ÅRETS RESULTAT ERRIA...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-27, 18:12
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-23, 14:14
Agillic announces 2022 results with 37.7% growth in total
Announcement no. 1-2023 Contain insider information Copenhagen – 23 February 2023 - Agillic A/S (Nasdaq First North Growth Market Denmark: AGILC)...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-22, 15:54
No. 1/2023 - Financial calendar 2023/2024
Nasdaq Copenhagen Nikolaj Plads 6 DK-1067 Copenhagen K Copenhagen,...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-22, 13:43
NKT seeks to increase share issuance authorization at
Company Announcement 22 February 2023 Announcement No. 1 NKT seeks to increase share issuance authorization at Annual General Meeting The Board of...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-09, 15:05
Transactions by persons discharging managerial
Disclosure 1 / 2023 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-08, 14:24
Upgraded outlook for 2023
Jyske Bank expects earnings per share of DKK 60-70, corresponding to a net profit of DKK 4.0bn - 4.6bn and a profit before tax of DKK 5.3bn - 6.1bn in...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-03, 21:06
Coloplast A/S - Allocation of Share Options
Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-03, 18:56
Regulatory filing for house dust mite allergy tablet
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that its Biologics License Application (BLA) for its house dust mite (HDM) sublingual allergy...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-03, 13:35
Coloplast A/S - Announcement no. 01/2023 – Interim
Q1 2022/23 Interim financial results, Q1 2022/23 1 October 2022 – 31 December 2022 Coloplast delivered a solid start to the year with 7%...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-01, 17:54
Addition to the Executive Management
To Nasdaq OMX Copenhagen A/S Public announcement no. 536 February 1st, 2023 ADDITION TO THE EXECUTIVE MANAGEMENT TEAM IN GLUNZ & JENSEN ...
